These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38714224)

  • 21. Risk, Outcomes, and Predictors of
    Bhandari S; Pandey RK; Dahal S; Shahreyar M; Dhakal B; Jha P; Venkatesan T; Saeian K
    South Med J; 2018 Oct; 111(10):628-633. PubMed ID: 30285271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of Clostridium difficile infections after cardiac surgery: epidemiologic and economic implications from national data.
    Flagg A; Koch CG; Schiltz N; Chandran Pillai A; Gordon SM; Pettersson GB; Soltesz EG
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2404-9. PubMed ID: 24823282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis.
    Ali M; Ananthakrishnan AN; Ahmad S; Kumar N; Kumar G; Saeian K
    Liver Transpl; 2012 Aug; 18(8):972-8. PubMed ID: 22505356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.
    Phatharacharukul P; Purpura RD; Gandhi D; Xu H; Bickett-Burkhart K; Chalasani N; Fischer M; Orman ES
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00189. PubMed ID: 32675703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
    Loomba R; Wong R; Fraysse J; Shreay S; Li S; Harrison S; Gordon SC
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1149-1159. PubMed ID: 32372515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing risk factors, mortality, and healthcare utilization associated with Clostridioides difficile infection in four Latin American countries.
    Yu H; Flaster N; Casanello AL; Curcio D
    Braz J Infect Dis; 2021; 25(1):101040. PubMed ID: 33290727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain.
    Romero-Gomez M; Kachru N; Zamorano MA; Darba J; Shreay S
    Medicine (Baltimore); 2020 Dec; 99(50):e23506. PubMed ID: 33327291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clostridium difficile infection in hospitalized children in the United States.
    Nylund CM; Goudie A; Garza JM; Fairbrother G; Cohen MB
    Arch Pediatr Adolesc Med; 2011 May; 165(5):451-7. PubMed ID: 21199971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of the outcomes of Clostridioides difficile occurring in intestinal transplant recipients requiring hospitalization.
    Amjad W; Schiano T; Segovia MC; Malik A; Weiner J; Horslen S; Jafri SM
    Transpl Infect Dis; 2023 Feb; 25(1):e13951. PubMed ID: 36621893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile infection in the USA: incidence and associated factors in revision total knee arthroplasty patients.
    Gwam CU; George NE; Etcheson JI; Tarazi JM; Han GR; Griffith KME; Mont MA; Delanois RE
    Eur J Orthop Surg Traumatol; 2019 Apr; 29(3):667-674. PubMed ID: 30350019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database.
    Pant C; Anderson MP; O'Connor JA; Marshall CM; Deshpande A; Sferra TJ
    Transpl Infect Dis; 2012 Oct; 14(5):540-7. PubMed ID: 22726461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease as a risk factor for Clostridium difficile-associated diarrhea.
    Nseir WB; Hussein SHH; Farah R; Mahamid MN; Khatib HH; Mograbi JM; Peretz A; Amara AE
    QJM; 2020 May; 113(5):320-323. PubMed ID: 31688897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression from Non-alcoholic Steatohepatitis to Advanced Liver Diseases and Mortality Among Medicare Patients.
    Kim Y; Medicis J; Davis M; Nunag D; Gish R
    Adv Ther; 2024 Nov; 41(11):4335-4355. PubMed ID: 39316292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcomes of
    Abdalla AO; Pisipati S; Elnaggar M; Rishi M; Doshi R; Gullapalli N
    Gastroenterology Res; 2020 Apr; 13(2):53-57. PubMed ID: 32362963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: A nationwide study.
    Ziakas PD; Joyce N; Zacharioudakis IM; Zervou FN; Besdine RW; Mor V; Mylonakis E
    Medicine (Baltimore); 2016 Aug; 95(31):e4187. PubMed ID: 27495022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
    Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Kiseleva YV; Maslennikov RV; Gadzhiakhmedova AN; Zharikova TS; Kalinin DV; Zharikov YO
    World J Hepatol; 2023 Feb; 15(2):208-215. PubMed ID: 36926243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clostridium difficile infection in patients with chronic kidney disease.
    Keddis MT; Khanna S; Noheria A; Baddour LM; Pardi DS; Qian Q
    Mayo Clin Proc; 2012 Nov; 87(11):1046-53. PubMed ID: 23127731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.